Impact of hormone receptor status and tumor subtypes on clinical behavior and outcomes of breast cancer in young BRCA carriers

被引：0

作者：

Arecco, Luca

Bruzzone, Marco

Hamy, Anne-Sophie

Kim, Hee Jeong

Di Meglio, Antonio

Bernstein-Molho, Rinat

Hilbers, Florentine

Pogoda, Katarzyna

Carrasco, Estela

Punie, Kevin

Bajpai, Jyoti

Agostinetto, Elisa

Lopetegui-Lia, Nerea

Partridge, Ann H.

Phillips, Kelly-Anne

Toss, Angela

Rousset-Jablonski, Christine

Curigliano, Giuseppe

Blondeaux, Eva

Lambertini, Matteo

机构：

[1] Univ Genoa, Dept Internal Med & Med Specialties DIMI, Sch Med, Genoa, Italy

[2] Hop Univ Bruxelles HUB, Acad Trials Promoting Team, Inst Jules Bordet, Brussels, Belgium

[3] IRCCS Osped Policlin San Martino, UO Epidemiol Clin, Genoa, Italy

[4] Univ Paris Cite, Dept Med Oncol, Inst Curie, Paris, France

[5] Univ Ulsan, Div Breast Surg, Dept Surg, Asan Med Ctr,Coll Med, Seoul, South Korea

[6] Gustave Roussy, Canc Survivorship Program, INSERM 981, Villejuif, France

[7] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Danek Gertner Inst Human Genet, Tel Hashomer, Israel

[8] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands

[9] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland

[10] Inst Oncol, Warsaw, Poland

[11] Vall dHebron Univ Hosp, Hereditary Canc Genet Unit, VHIO, Dept Med Oncol, Barcelona, Spain

[12] Univ Hosp, Dept Gen Med Oncol, Leuven, Belgium

[13] Univ Hosp, Multidisciplinary Breast Ctr, Leuven Canc Inst, Leuven, Belgium

[14] Tata Mem Hosp, Mumbai, India

[15] ULB, HUB, ATPT, Brussels, Belgium

[16] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH USA

[17] Dana Farber Canc Inst, Boston, MA USA

[18] Univ Melbourne, Dept Med Oncol, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[19] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[20] Univ Melbourne, Ctr Epidemiol & Biostat, Sch Populat & Global Hlth, Melbourne, Vic, Australia

[21] Univ Hosp Modena, Dept Haematol & Oncol, Modena, Italy

[22] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Modena, Italy

[23] Claude Bernard Lyon 1 Univ, Dept Surg, Ctr Leon Berard, Unite INSERM U1290 RESHAPE, Lyon, France

[24] IRCCS, European Inst Oncol, Milan, Italy

[25] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy

[26] IRCCS Osped Policlin San Martino, Clin Epidemiol Unit, Genoa, Italy

[27] Univ Genoa, Dept Internal Med & Med Specialties DIMI, Sch Med, Genoa, Italy

[28] IRCCS Osped Policlin San Martino, UOC Clin Oncol Med, Dept Med Oncol, Genoa, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

504

引用

页数：1

共 50 条

[31] Clinical outcomes in BRCA mutation carriers treated with breast conserving therapy
Wanis, Kerollos N.
Kuerer, Henry M.
Sun, Susie X.
Hunt, Kelly K.
Glencer, Alexa C.
Teshome, Mediget
Lucci, Anthony
Weiser, Roi
Johnson, Helen M.
Smith, Benjamin D.
Gutierrez, Angelica M.
Shaitelman, Simona F.
Arun, Banu K.
ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S9 - S9
[32] Discordance in hormone receptor status in breast cancer during tumor progression.
Karlsson, E.
Lindstrom, L. S.
Wilking, U.
Skoog, L.
Johansson, U.
Bergh, J.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[33] Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers
Vocka, Michal
Zimovjanova, Martina
Bielcikova, Zuzana
Tesarova, Petra
Petruzelka, Lubos
Mateju, Martin
Krizova, Ludmila
Kotlas, Jaroslav
Soukupova, Jana
Janatova, Marketa
Zemankova, Petra
Kleiblova, Petra
Novotny, Jan
Konopasek, Bohuslav
Chodacka, Martina
Brychta, Milan
Sochor, Marek
Smejkalova-Musilova, Denisa
Cmejlova, Vlastimila
Kozevnikovova, Renata
Miskarova, Lenka
Argalacsova, Sona
Stolarova, Lenka
Lhotova, Klara
Borecka, Marianna
Kleibl, Zdenek
CANCERS, 2019, 11 (06):
[34] Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
Karoline B Kuchenbaecker
Susan L Neuhausen
Mark Robson
Daniel Barrowdale
Lesley McGuffog
Anna Marie Mulligan
Irene L Andrulis
Amanda B Spurdle
Marjanka K Schmidt
Rita K Schmutzler
Christoph Engel
Barbara Wappenschmidt
Heli Nevanlinna
Mads Thomassen
Melissa Southey
Paolo Radice
Susan J Ramus
Susan M Domchek
Katherine L Nathanson
Andrew Lee
Sue Healey
Robert L Nussbaum
Timothy R Rebbeck
Banu K Arun
Paul James
Beth Y Karlan
Jenny Lester
Ilana Cass
Breast Cancer Family Registry
Mary Beth Terry
Mary B Daly
David E Goldgar
Saundra S Buys
Ramunas Janavicius
Laima Tihomirova
Nadine Tung
Cecilia M Dorfling
Elizabeth J van Rensburg
Linda Steele
Thomas v O Hansen
Bent Ejlertsen
Anne-Marie Gerdes
Finn C Nielsen
Joe Dennis
Julie Cunningham
Steven Hart
Susan Slager
Ana Osorio
Javier Benitez
Mercedes Duran
Breast Cancer Research, 16
[35] Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
Kuchenbaecker, Karoline B.
Neuhausen, Susan L.
Robson, Mark
Barrowdale, Daniel
McGuffog, Lesley
Mulligan, Anna Marie
Andrulis, Irene L.
Spurdle, Amanda B.
Schmidt, Marjanka K.
Schmutzler, Rita K.
Engel, Christoph
Wappenschmidt, Barbara
Nevanlinna, Heli
Thomassen, Mads
Southey, Melissa
Radice, Paolo
Ramus, Susan J.
Domchek, Susan M.
Nathanson, Katherine L.
Lee, Andrew
Healey, Sue
Nussbaum, Robert L.
Rebbeck, Timothy R.
Arun, Banu K.
James, Paul
Karlan, Beth Y.
Lester, Jenny
Cass, Ilana
Terry, Mary Beth
Daly, Mary B.
Goldgar, David E.
Buys, Saundra S.
Janavicius, Ramunas
Tihomirova, Laima
Tung, Nadine
Dorfling, Cecilia M.
van Rensburg, Elizabeth J.
Steele, Linda
Hansen, Thomas V. O.
Ejlertsen, Bent
Gerdes, Anne-Marie
Nielsen, Finn C.
Dennis, Joe
Cunningham, Julie
Hart, Steven
Slager, Susan
Osorio, Ana
Benitez, Javier
Duran, Mercedes
Weitzel, Jeffrey N.
BREAST CANCER RESEARCH, 2014, 16
[36] Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers
Eisen, Andrea
Lubinski, Jan
Gronwald, Jacek
Moller, Pal
Lynch, Henry T.
Klijn, Jan
Kim-Sing, Charmaine
Neuhausen, Susan L.
Gilbert, Lucy
Ghadirian, Parviz
Manoukian, Siranoush
Rennert, Gad
Friedman, Eitan
Isaacs, Claudine
Rosen, Eliot
Rosen, Barry
Daly, Mary
Sun, Ping
Narod, Steven A.
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (19) : 1361 - 1367
[37] Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers
Osin, P
Crook, T
Powles, T
Peto, J
Gusterson, B
LANCET, 1998, 351 (9114): : 1487 - 1487
[38] HORMONE RECEPTOR STATUS AND CHEMOSENSITIVITYIN BREAST CANCER
黄信孚
杨兰桂
何洛文
张慧颖
Chinese Journal of Cancer Research, 1988, (00) : 19 - 23
[39] Assessment of hormone receptor status in breast cancer
Horii, Rie
Akiyama, Futoshi
Ito, Yoshinori
Iwase, Takuji
PATHOLOGY INTERNATIONAL, 2007, 57 (12) : 784 - 790
[40] Impact of prior knowledge of mutation status on tumor stage in BRCA1/2 mutation carriers with newly diagnosed breast cancer.
Yam, Clinton
Stopfer, Jill
Brandt, Amanda
Powers, Jacquelyn
Long, Jessica M.
Maxwell, Kara Noelle
Bradbury, Angela R.
Nathanson, Katherine L.
Domchek, Susan M.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →